Suppr超能文献

针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的个人防护措施和抗病毒药物的比较性能评估:一项叙述性综述

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review.

作者信息

Haque Md Anamul, Tanbir Md, Ahamed Bulbul, Hossain Md Jamal, Roy Arpita, Shahriar Mohammad, Bhuiyan Mohiuddin Ahmed, Islam Md Rabiul

机构信息

Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.

Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh.

出版信息

Clin Pathol. 2023 Mar 13;16:2632010X231161222. doi: 10.1177/2632010X231161222. eCollection 2023 Jan-Dec.

Abstract

Scientists identified SARS-CoV-2 in December 2019 in Wuhan city of China. Soon after its identification, Covid-19 spreads almost everywhere. The World Health Organization (WHO) declared the Covid-19 outbreak as a pandemic on March 11, 2020. Countries are facing multiple waves due to the different variants of the coronavirus. Personal preventive measures, vaccines, and antiviral drugs are the approaches to control Covid-19. However, these approaches are being implemented in different countries at different levels because of the availability of personal protective measures and antiviral agents. The objective of this study was to evaluate the effectiveness of practicing measures to fight the Covid-19 pandemic. Here we searched relevant literature from PubMed and Scopus using the keywords such as personal protective measures, antiviral agents, and vaccine effectiveness. According to the present findings, protective measures were found comparatively less effective. Nevertheless, these measures can be used to limit the spreading of Covid-19. Antiviral agents can reduce the hospitalization rate and are more effective than personal protective measures. The most effective strategy against Covid-19 is early vaccination or multiple vaccination dose. The respective authorities should ensure equal distribution of vaccines, free availability of antiviral drugs, and personal protective measure in poor and developing countries. We recommend more studies to describe the effectiveness of practicing preventive measures and antiviral agents against recent variants of the coronavirus.

摘要

2019年12月,科学家在中国武汉市发现了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。该病毒被发现后不久,新冠肺炎几乎蔓延到了世界各地。2020年3月11日,世界卫生组织(WHO)宣布新冠肺炎疫情为大流行。由于冠状病毒的不同变种,各国正面临多波疫情。个人预防措施、疫苗和抗病毒药物是控制新冠肺炎的方法。然而,由于个人防护措施和抗病毒药物的可获得性,这些方法在不同国家的实施程度各不相同。本研究的目的是评估实施应对新冠肺炎大流行措施的有效性。我们使用个人防护措施、抗病毒药物和疫苗有效性等关键词在PubMed和Scopus上搜索了相关文献。根据目前的研究结果,发现防护措施的效果相对较差。尽管如此,这些措施可用于限制新冠肺炎的传播。抗病毒药物可以降低住院率,并且比个人防护措施更有效。对抗新冠肺炎最有效的策略是早期接种疫苗或多次接种疫苗。各国当局应确保在贫穷国家和发展中国家公平分配疫苗、免费提供抗病毒药物以及提供个人防护措施。我们建议开展更多研究,以描述实施预防措施和抗病毒药物对抗击冠状病毒最新变种的有效性。

相似文献

本文引用的文献

10
Inactivated vaccine Covaxin/BBV152: A systematic review.灭活疫苗Covaxin/BBV152:一项系统评价。
Front Immunol. 2022 Aug 9;13:863162. doi: 10.3389/fimmu.2022.863162. eCollection 2022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验